Multiple Myeloma Autologous Stem Cell Transplant

Autologous stem cell transplant multiple myeloma time factors abstract as multiple myeloma mm treatments evolve frequent updates are required to monitor the long term effect of changes in approach.

Multiple myeloma autologous stem cell transplant.

The widespread use of high dose therapy and autologous stem cell transplantation asct as well as the introduction of novel agents have significantly improved outcomes in multiple myeloma mm enabling long term survival. In a stem cell transplant the patient gets high dose chemotherapy to kill the cells in the bone marrow. Since high dose treatment destroys the normal bone marrow in addition to the myeloma cells the collected stem cells are unfrozen and given back into the bloodstream through an intravenous into a vein catheter one to two days after administration of the high dose chemotherapy. We here analyze factors influencing survival in 865 newly diagnosed mm patien.

Autologous and allogeneic stem cell transplants. Then the patient receives new healthy blood forming stem cells. A stem cell transplant replaces unhealthy blood cells with healthy ones. It isn t a cure but compared to chemotherapy alone a.

Stem cell transplant for multiple myeloma. A stem cell transplant in combination with high dose chemotherapy is a treatment option that offers a chance for durable remission for people with multiple myeloma. It can be a strong weapon in your fight against multiple myeloma.